Effectiveness and safety of adjunctive cenobamate in people with focal‐onset epilepsy: Interim results after 24‐week observational period from the <scp>BLESS</scp> studySimona Lattanzi, Gabriele Camattari, Fedele Dono et al.|Epilepsia|2025Cited by 18
Phenotypic Spectrum in Individuals With Pathogenic <i>GABRG2</i> Loss- and Gain-of-Function VariantsAlessandra Rossi, Renzo Guerrini, Sindhu Viswanathan et al.|Neurology|2025Cited by 10
Brivaracetam use in clinical practice: a Delphi consensus on its role as first add-on therapy in focal epilepsy and beyondSimona Lattanzi, Stella Vergine, Valentina Chiesa et al.|Neurological Sciences|2024Cited by 5